Kubota Pharmaceutical Holdings Co., Ltd.

Tokyo Stock Exchange 4596.T

Kubota Pharmaceutical Holdings Co., Ltd. Market Capitalization on January 14, 2025: USD 18.21 M

Kubota Pharmaceutical Holdings Co., Ltd. Market Capitalization is USD 18.21 M on January 14, 2025, a -32.77% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Kubota Pharmaceutical Holdings Co., Ltd. 52-week high Market Capitalization is USD 30.94 M on August 01, 2024, which is 69.91% above the current Market Capitalization.
  • Kubota Pharmaceutical Holdings Co., Ltd. 52-week low Market Capitalization is USD 17.59 M on December 24, 2024, which is -3.38% below the current Market Capitalization.
  • Kubota Pharmaceutical Holdings Co., Ltd. average Market Capitalization for the last 52 weeks is USD 23.47 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Tokyo Stock Exchange: 4596.T

Kubota Pharmaceutical Holdings Co., Ltd.

CEO Dr. Ryo Kubota M.D., Ph.D.
IPO Date Dec. 6, 2016
Location Japan
Headquarters 3-7-1 Kasumigaseki
Employees 12
Sector Health Care
Industries
Pharmaceuticals
Description

Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email